Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ABL kinase domain pseudoexon insertion is not uncommon in BCR-ABL transcripts.

× No keyword cloud information.

4 in total

Review 1. Listening to silence and understanding nonsense: exonic mutations that affect splicing.

Authors: Luca Cartegni; Shern L Chew; Adrian R Krainer
Journal: Nat Rev Genet Date: 2002-04 Impact factor: 53.242

2. Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia.

Authors: D W Sherbenou; O Hantschel; L Turaga; I Kaupe; S Willis; T Bumm; R D Press; G Superti-Furga; B J Druker; M W Deininger
Journal: Leukemia Date: 2008-03-20 Impact factor: 11.528

3. An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy.

Authors: Jennifer Laudadio; Michael W N Deininger; Michael J Mauro; Brian J Druker; Richard D Press
Journal: J Mol Diagn Date: 2008-02-14 Impact factor: 5.568

4. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.

Authors: Gisella Volpe; Alessandro Cignetti; Cristina Panuzzo; Mirela Kuka; Katiuscia Vitaggio; Mara Brancaccio; Giuseppe Perrone; Monica Rinaldi; Giuseppina Prato; Milena Fava; Massimo Geuna; Marisa Pautasso; Claudia Casnici; Emanuela Signori; Giancarlo Tonon; Guido Tarone; Ornella Marelli; Vito M Fazio; Giuseppe Saglio
Journal: Cancer Res Date: 2007-06-01 Impact factor: 12.701

4 in total

1. Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology.

Authors: Dan Jones; Suzanne Kamel-Reid; David Bahler; Henry Dong; Kojo Elenitoba-Johnson; Richard Press; Neil Quigley; Paul Rothberg; Dan Sabath; David Viswanatha; Karen Weck; James Zehnder
Journal: J Mol Diagn Date: 2008-12-18 Impact factor: 5.568

ABL kinase domain pseudoexon insertion is not uncommon in BCR-ABL transcripts.

Review 1. Listening to silence and understanding nonsense: exonic mutations that affect splicing.

2. Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia.

3. An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy.

4. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.

1. Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology.

2. Alternative splicing in oncogenic kinases: from physiological functions to cancer.

Review 3. Role of pseudoexons and pseudointrons in human cancer.

4. Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Thyroid Carcinoma.